Genetically engineered mouse models of pancreatic cancer.
about
GEMMs as preclinical models for testing pancreatic cancer therapiesGenetically engineered mouse models of pancreatic adenocarcinomaInfluence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenograftsmiR-29a-deficiency does not modify the course of murine pancreatic acinar carcinoma.No Functional Role for microRNA-342 in a Mouse Model of Pancreatic Acinar Carcinoma.Optimizing mouse models for precision cancer prevention.Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations.LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer.Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies.Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma.Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer.Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.Malnutrition in Pancreatic Ductal Adenocarcinoma (PDA): Dietary Pancreatic Enzymes Improve Short-Term Health but Stimulate Tumor Growth.Berries and other natural products in the pancreatic cancer chemoprevention in human clinical trials.Understanding Disease Biology and Informing the Management of Pancreas Cancer With Preclinical Model Systems.Translational molecular imaging in exocrine pancreatic cancerDifferentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells
P2860
Q26781848-0CA2F2F5-1265-4393-8939-9DE935500C01Q27002973-AAEE2290-DC95-4930-8C8B-B87EBE898BC3Q27321370-DB2FA0EE-974D-4A8D-9DFF-E49238AC8375Q33688864-8C5BE3E2-A070-445C-B45F-A3B117D4E3FFQ33700748-CCBB1BB8-D475-4803-989C-633A965027CDQ33919192-626352EF-C455-4CFF-A040-22343252CBBCQ34017017-7A5F67D8-374D-4E9A-9099-CB562707D672Q36364191-A5E88864-60E9-4D10-B15A-4908BC599904Q37024754-3271EC57-3EC6-4F29-8321-CF1378EC4D5FQ38818544-E8E1CC6F-AD73-4B99-90B2-01419E6ED772Q39108406-7945A225-FAE6-4D68-9796-A08D77EA09FFQ41983217-BB0BD69A-82F7-4AA0-AF8A-5BA483BF274FQ46812947-FF91403D-1D8D-4060-ADC1-C000FCDDC6F2Q47150678-A02D852D-CBB4-46DA-ACEC-43EE963BCF0AQ47285433-424BE757-59CA-4E06-8306-DAA062EDF2E2Q49415169-4319B995-49C9-4CAB-8FA3-03B982382C11Q49494945-DCCC3289-BE7E-4D66-870A-3B52DA8C3BBCQ58728351-650A3948-C5B8-46FB-A773-509DAA48C53FQ58761872-12930097-2F78-4DF7-A1E3-CC877E0ACBC2
P2860
Genetically engineered mouse models of pancreatic cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Genetically engineered mouse models of pancreatic cancer.
@ast
Genetically engineered mouse models of pancreatic cancer.
@en
type
label
Genetically engineered mouse models of pancreatic cancer.
@ast
Genetically engineered mouse models of pancreatic cancer.
@en
prefLabel
Genetically engineered mouse models of pancreatic cancer.
@ast
Genetically engineered mouse models of pancreatic cancer.
@en
P2860
P1433
P1476
Genetically engineered mouse models of pancreatic cancer.
@en
P2093
Christoph Benedikt Westphalen
Kenneth P Olive
P2860
P304
P356
10.1097/PPO.0B013E31827AB4C4
P577
2012-11-01T00:00:00Z